{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:46Z","timestamp":1788581566153,"version":"build-2803163510"},"reference-count":43,"publisher":"Center for Academic Publications Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.3177\/jnsv.72.343","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:12:12Z","timestamp":1788127932000},"page":"343-351","source":"Crossref","is-referenced-by-count":0,"title":["Agaro-Oligosaccharides Modulate Gut Microbiota to Improve Lipid Metabolism in Obesity Model Rats"],"prefix":"10.3177","volume":"72","author":[{"given":"Kento","family":"KURAMITSU","sequence":"first","affiliation":[{"name":"Department of Applied Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"KITAURA","sequence":"additional","affiliation":[{"name":"Department of Applied Biosciences, Chubu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"KARASAWA","sequence":"additional","affiliation":[{"name":"Ina Food Industry Co., Ltd."},{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasia","family":"HOSHIBA","sequence":"additional","affiliation":[{"name":"Ina Food Industry Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"FUJII","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University"},{"name":"BIOSIS Lab. Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"TAKAHASHI","sequence":"additional","affiliation":[{"name":"BIOSIS Lab. Co., Ltd."},{"name":"Graduate School of Nutritional Sciences, Nagoya University of Arts and Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizaburo","family":"OHNO","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"FUNASAKA","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"HIROOKA","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University"},{"name":"BIOSIS Lab. Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"TOCHIO","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Fujita Health University"},{"name":"Department of Medical Research on Prebiotics and Probiotics, Fujita Health University"},{"name":"BIOSIS Lab. Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Imamura F, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, Mozaffarian D; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). 2015. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health 3: 132-142.","DOI":"10.1016\/S2214-109X(14)70381-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) NCD Risk Factor Collaboration (NCD-RisC). 2016. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387: 1377-1396.","DOI":"10.1016\/S0140-6736(16)30054-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lavie CJ, Milani RV, Ventura HO. 2009. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53: 1925-1932.","DOI":"10.1016\/j.jacc.2008.12.068"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kopelman PG. 2000. Obesity as a medical problem. Nature 404: 635-643.","DOI":"10.1038\/35007508"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.","DOI":"10.1126\/science.1241214"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Takeuchi T, Kameyama K, Miyauchi E, Nakanishi Y, Kanaya T, Fujii T, Kato T, Sasaki T, Tachibana N, Negishi H, Matsui M, Ohno H. 2023. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab 35: 361-375.","DOI":"10.1016\/j.cmet.2022.12.013"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wu C, Yang F, Zhong H, Hong J, Lin H, Zong M, Ren H, Zhao S, Chen Y, Shi Z, Wang X, Shen J, Wang Q, Ni M, Chen B, Cai Z, Zhang M, Cao Z, Wu K, Gao A, Li J, Liu C, Xiao M, Li Y, Shi J, Zhang Y, Xu X, Gu W, Bi Y, Ning G, Wang W, Wang J, Liu R. 2024. Obesity-enriched gut microbe degrades myo-inositol and promotes lipid absorption. Cell Host Microbe 32: 1301-1314.","DOI":"10.1016\/j.chom.2024.06.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, Verbeke K, Reid G. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14: 491-502.","DOI":"10.1038\/nrgastro.2017.75"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Higashimura Y, Naito Y, Takagi T, Mizushima K, Hirai Y, Harusato A, Ohnogi H, Yamaji R, Inui H, Nakano Y, Yoshikawa T. 2013. Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression. J Gastroenterol 48: 897-909.","DOI":"10.1007\/s00535-012-0719-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Higashimura Y, Naito Y, Takagi T, Uchiyama K, Mizushima K, Ushiroda C, Ohnogi H, Kudo Y, Yasui M, Inui S, Hisada T, Honda A, Matsuzaki Y, Yoshikawa T. 2016. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am J Physiol Gastrointest Liver Physiol 310: 367-375.","DOI":"10.1152\/ajpgi.00324.2015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lee MR, Kim JE, Jin YJ, Roh YJ, Seol A, Song HJ, Jung MW, Hong JT, Jang M, Hwang DY. 2022. Antiobesity effects of agar (<i>Gelidium amansii<\/i>)derived oligosaccharides in highfat diettreated C57BL\/6N mice due to differential regulations of lipogenesis and lipolysis. Biosci Biotechnol Biochem 86: 1648-1657.","DOI":"10.1093\/bbb\/zbac159"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.","DOI":"10.1139\/y59-099"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. 2014. Development of a prokaryotic universal primer for simultaneous analysis of bacteria and archaea using nextgeneration sequencing. PLoS One 9: e105592.","DOI":"10.1371\/journal.pone.0105592"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodr\u00edguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu YX, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, McDonald D, McIver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MS 2nd, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, V\u00e1zquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, Williamson CHD, Willis AD, Xu ZZ, Zaneveld JR, Zhang Y, Zhu Q, Knight R, Caporaso JG. 2019. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37: 852-857.","DOI":"10.7287\/peerj.preprints.27295v2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. 2016. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods 13: 581-583.","DOI":"10.1038\/nmeth.3869"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Caporaso JG. 2018. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6: 90.","DOI":"10.1186\/s40168-018-0470-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Takahashi H, Fujii T, Yamakawa S, Yamada C, Fujiki K, Kondo N, Funasaka K, Hirooka Y, Tochio T. 2023. Combined oral intake of short and long fructans alters the gut microbiota in food allergy model mice and contributes to food allergy prevention. BMC Microbiol 23: 266.","DOI":"10.1186\/s12866-023-03021-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zhu M, Jia Z, Yan X, Liu L, Fang C, Feng M, Dai Y, Zhang Y, Wu H, Huang B, Li Y, Liu J, Xiao H. 2022. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK. J Ethnopharmacol 295: 115427.","DOI":"10.1016\/j.jep.2022.115427"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Zhou Y, Zhang X, Chen L, Wu J, Dang H, Wei MF, Fan Y, Zhang Y, Zhu Y, Wang N, Breyer MD, Guan Y. 2008. Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Am J Physiol Renal Physiol 295: 662-671.","DOI":"10.1152\/ajprenal.00046.2008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) GodoyLugo JA, Mendez DA, Rodriguez R, Nishiyama A, Nakano D, So\u00f1anez-Organis JG, Ortiz RM. 2022. Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 17 after AT1 receptor blockade in insulinresistant OLETF rats. Mol Cell Endocrinol 555: 111729.","DOI":"10.1016\/j.mce.2022.111729"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Cho IJ, Oh DH, Yoo J, Hwang YC, Ahn KJ, Chung HY, Jeong SW, Moon JY, Lee SH, Lim SJ, Jeong IK. 2021. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. Sci Rep 11: 989.","DOI":"10.1038\/s41598-021-88872-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Schroeder M, Shbiro L, ZagoorySharon O, Moran TH, Weller A. 2009. Development of obesity in the Otsuka LongEvans Tokushima Fatty rat. Am J Physiol Regul Integr Comp Physiol 297: 1749-1760.","DOI":"10.1152\/ajpregu.00461.2009"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Bi S, Scott KA, Hyun J, Ladenheim EE, Moran TH. 2005. Running wheel activity prevents hyperphagia and obesity in Otsuka LongEvans Tokushima Fatty rats: role of hypothalamic signaling. Endocrinology 146: 1676-1685.","DOI":"10.1210\/en.2004-1441"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Takemura S, Minamiyama Y, Kodai S, Shinkawa H, Tsukioka T, Okada S, Azuma H, Kubo S. 2013. SAllyl cysteine improves nonalcoholic fatty liver disease in type 2 diabetes Otsuka LongEvans Tokushima Fatty rats via regulation of hepatic lipogenesis and glucose metabolism. J Clin Biochem Nutr 53: 94-101.","DOI":"10.3164\/jcbn.13-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Man ZW, Zhu M, Noma Y, Toide K, Sato T, Asahi Y, Hirashima T, Mori S, Kawano K, Mizuno A, Sano T, Shima K. 1997. Impaired betacell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes 46: 1718-1724.","DOI":"10.2337\/diabetes.46.11.1718"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Derrien M, Belzer C, de Vos WM. 2017. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog 106: 171-181.","DOI":"10.1016\/j.micpath.2016.02.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wu W, Kaicen W, Bian X, Yang L, Ding S, Li Y, Li S, Zhuge A, Li L. 2023. Akkermansia muciniphila alleviates highfatdietrelated metabolicassociated fatty liver disease by modulating gut microbiota and bile acids. Microb Biotechnol 16: 1924-1939.","DOI":"10.1111\/1751-7915.14293"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kim S, Lee Y, Kim Y, Seo Y, Lee H, Ha J, Lee J, Choi Y, Oh H, Yoon Y. 2020. Akkermansia muciniphila prevents fatty liver disease, decreases serum triglycerides, and maintains gut homeostasis. Appl Environ Microbiol 86: e03004-19.","DOI":"10.1128\/AEM.03004-19"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, Takahashi T, Miyauchi S, Shioi G, Inoue H, Tsujimoto G. 2013. The gut microbiota suppresses insulinmediated fat accumulation via the shortchain fatty acid receptor GPR43. Nat Commun 4: 1829.","DOI":"10.1038\/ncomms2852"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. 2016. Short chain fatty acids prevent highfatdietinduced obesity in mice by regulating G proteincoupled receptors and gut microbiota. Sci Rep 6: 37589.","DOI":"10.1038\/srep37589"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donachie GE, Hardt PD. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18: 190-195.","DOI":"10.1038\/oby.2009.167"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Rau M, Rehman A, Dittrich M, Groen AK, Hermanns HM, Seyfried F, Beyersdorf N, Dandekar T, Rosenstiel P, Geier A. 2018. Fecal SCFAs and SCFAproducing bacteria in gut microbiome of human NAFLD as a putative link to systemic Tcell activation and advanced disease. United European Gastroenterol J 6: 1496-1507.","DOI":"10.1177\/2050640618804444"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) De Vadder F, KovatchevaDatchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G. 2014. Microbiotagenerated metabolites promote metabolic benefits via gutbrain neural circuits. Cell 156: 84-96.","DOI":"10.1016\/j.cell.2013.12.016"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, Zeng X, Trefely S, Fernandez S, Carrer A, Miller KD, Schug ZT, Snyder NW, Gade TP, Titchenell PM, Rabinowitz JD, Wellen KE. 2020. Dietary fructose feeds hepatic lipogenesis via microbiotaderived acetate. Nature 579: 586-591.","DOI":"10.1038\/s41586-020-2101-7"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. 1999. Identification of a nuclear receptor for bile acids. Science 284: 1362-1365.","DOI":"10.1126\/science.284.5418.1362"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ. 2015. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 125: 386-402.","DOI":"10.1172\/JCI76738"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Eberl\u00e9 D, Hegarty B, Bossard P, Ferr\u00e9 P, Foufelle F. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848.","DOI":"10.1016\/j.biochi.2004.09.018"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Bitter A, N\u00fcssler AK, Thasler WE, Klein K, Zanger UM, Schwab M, Burk O. 2015. Human sterol regulatory elementbinding protein 1a contributes significantly to hepatic lipogenic gene expression. Cell Physiol Biochem 35: 803-815.","DOI":"10.1159\/000369739"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Higashimura Y, Baba Y, Inoue R, Takagi T, Mizushima K, Ohnogi H, Honda A, Matsuzaki Y, Naito Y. 2017. Agarooligosaccharides regulate gut microbiota and adipose tissue accumulation in mice. J Nutr Sci Vitaminol 63: 269-276.","DOI":"10.3177\/jnsv.63.269"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Fujii T, Karasawa K, Takahashi H, Shirai I, Funasaka K, Ohno E, Hirooka Y, Tochio T. 2024. Agarooligosaccharides as a novel concept in prebiotics: selective inhibition of <i>Ruminococcus gnavus<\/i> and <i>Fusobacterium nucleatum<\/i> while preserving Bifidobacteria, Lactobacillales in vitro, and inhibiting Lachnospiraceae in vivo. Microbiology (Reading) 170: 001510.","DOI":"10.1099\/mic.0.001510"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Wang Q, Wang Y, Wang Y, Dai H, Cui S, Wu H, Xia H, Liu Y, Xiao H. 2024. Agarooligosaccharides mitigate deoxynivalenolinduced intestinal inflammation by regulating gut microbiota and enhancing intestinal barrier function in mice. Food Funct 15: 3380-3394.","DOI":"10.1039\/D3FO04898E"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Thakare R, Alamoudi JA, Gautam N, Rodrigues AD, Alnouti Y. 2018. Species differences in bile acids I. Plasma and urine bile acid composition. J Appl Toxicol 38: 1323-1335.","DOI":"10.1002\/jat.3644"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Nguyen TL, VieiraSilva S, Liston A, Raes J. 2015. How informative is the mouse for human gut microbiota research? Dis Model Mech 8: 1-16.","DOI":"10.1242\/dmm.017400"}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/72\/4\/72_343\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:42:02Z","timestamp":1788579722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/72\/4\/72_343\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.72.343","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"value":"0301-4800","type":"print"},{"value":"1881-7742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}